10 Best Undervalued Stocks Smart Money Is Buying for January 2026
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Market Overview & Selection Criteria
In the current market environment, investors are seeking undervalued stocks with strong fundamentals amid volatility in technology, healthcare, and commodities. Value Sense selected these 10 best stock picks using proprietary intrinsic value calculations, quality ratings, and key metrics like ROIC, FCF margins, and revenue growth. Stocks were filtered for significant upside potential where intrinsic value exceeds current implied pricing, prioritizing high-quality businesses with robust financial health. This watchlist emphasizes diversification across sectors, focusing on companies showing positive 1Y returns and attractive growth profiles for long-term analysis.
Featured Stock Analysis
Stock #1: Taiwan Semiconductor Manufacturing Company Limited (TSM)
| Metric | Value |
|---|---|
| Market Cap | $1,638.1B |
| Quality Rating | 8.2 |
| Intrinsic Value | $485.3 |
| 1Y Return | 58.6% |
| Revenue | NT$3,631.4B |
| Free Cash Flow | NT$889.9B |
| Revenue Growth | 37.0% |
| FCF margin | 24.5% |
| Gross margin | 59.0% |
| ROIC | 36.2% |
| Total Debt to Equity | 19.0% |
Investment Thesis
Taiwan Semiconductor Manufacturing Company Limited (TSM) stands out with a Quality rating of 8.2 and an intrinsic value of $485.3, suggesting substantial undervaluation in the semiconductor sector. The company reports a massive market cap of $1,638.1B, impressive revenue of NT$3,631.4B, and free cash flow of NT$889.9B. With revenue growth at 37.0%, FCF margin of 24.5%, gross margin of 59.0%, and ROIC of 36.2%, TSM demonstrates exceptional profitability and capital efficiency. Its low Total Debt to Equity of 19.0% underscores financial stability, complemented by a solid 1Y return of 58.6%. This positions TSM as a leader in advanced chip manufacturing, ideal for investors analyzing technology-driven growth.
Key Catalysts
- Explosive 37.0% revenue growth fueling expansion in AI and high-performance computing chips
- High ROIC of 36.2% indicating superior capital allocation and operational excellence
- Strong FCF generation at NT$889.9B supporting dividends, buybacks, and R&D investments
- Leading gross margin of 59.0% from pricing power in foundry services
Risk Factors
- Geopolitical tensions in Taiwan impacting supply chain reliability
- Cyclical semiconductor demand fluctuations
- High market cap exposure to global economic slowdowns
Stock #2: AbbVie Inc. (ABBV)
| Metric | Value |
|---|---|
| Market Cap | $407.0B |
| Quality Rating | 6.4 |
| Intrinsic Value | $301.8 |
| 1Y Return | 29.0% |
| Revenue | $59.6B |
| Free Cash Flow | $20.6B |
| Revenue Growth | 7.4% |
| FCF margin | 34.5% |
| Gross margin | 76.2% |
| ROIC | 12.0% |
| Total Debt to Equity | (2,645.0%) |
Investment Thesis
AbbVie Inc. (ABBV) offers a Quality rating of 6.4 and intrinsic value of $301.8, highlighting value in the healthcare sector with a $407.0B market cap. Key metrics include revenue of $59.6B, free cash flow of $20.6B, revenue growth of 7.4%, FCF margin of 34.5%, gross margin of 76.2%, and ROIC of 12.0%. Despite a high Total Debt to Equity of 2,645.0%, its 1Y return of 29.0% reflects resilience in biopharmaceuticals, particularly immunology drugs. This analysis reveals ABBV's potential for steady cash flows and pipeline-driven upside.
Key Catalysts
- Exceptional 76.2% gross margin from high-margin drug portfolio
- Robust FCF of $20.6B enabling debt management and acquisitions
- Consistent 7.4% revenue growth from blockbuster drugs
- 29.0% 1Y return signaling market confidence in healthcare stability
Risk Factors
- Elevated debt levels at 2,645.0% Total Debt to Equity posing refinancing risks
- Patent cliffs on key products like Humira
- Regulatory pressures in pharmaceuticals
Stock #3: Alibaba Group Holding Limited (BABA)
| Metric | Value |
|---|---|
| Market Cap | $360.4B |
| Quality Rating | 6.4 |
| Intrinsic Value | $312.9 |
| 1Y Return | 83.3% |
| Revenue | CN¥1,012.1B |
| Free Cash Flow | (CN¥26.9B) |
| Revenue Growth | 5.2% |
| FCF margin | (2.7%) |
| Gross margin | 41.2% |
| ROIC | 10.5% |
| Total Debt to Equity | 25.3% |
Investment Thesis
Alibaba Group Holding Limited (BABA), with a $360.4B market cap, earns a Quality rating of 6.4 and intrinsic value of $312.9. Metrics show revenue of CN¥1,012.1B, negative free cash flow of (CN¥26.9B), revenue growth of 5.2%, FCF margin of 2.7%, gross margin of 41.2%, ROIC of 10.5%, and Total Debt to Equity of 25.3%. A standout 1Y return of 83.3% indicates recovery potential in e-commerce and cloud computing, making it a compelling undervalued stock for China exposure analysis.
Key Catalysts
- 83.3% 1Y return driven by cloud and international expansion
- Solid ROIC of 10.5% from core e-commerce dominance
- Improving revenue growth at 5.2% amid regulatory easing
- Manageable debt at 25.3% supporting investments
Risk Factors
- Negative FCF of (CN¥26.9B) from heavy capex spending
- Geopolitical and regulatory risks in China
- Competitive pressures in cloud services
Stock #4: Micron Technology, Inc. (MU)
| Metric | Value |
|---|---|
| Market Cap | $345.8B |
| Quality Rating | 8.2 |
| Intrinsic Value | $435.3 |
| 1Y Return | 261.0% |
| Revenue | $42.3B |
| Free Cash Flow | $17.3B |
| Revenue Growth | 45.4% |
| FCF margin | 40.9% |
| Gross margin | 45.3% |
| ROIC | 25.4% |
| Total Debt to Equity | 20.2% |
Investment Thesis
Micron Technology, Inc. (MU) boasts a Quality rating of 8.2 and intrinsic value of $435.3, with a $345.8B market cap in memory chips. Financials include revenue of $42.3B, free cash flow of $17.3B, revenue growth of 45.4%, FCF margin of 40.9%, gross margin of 45.3%, ROIC of 25.4%, and Total Debt to Equity of 20.2%. Exceptional 1Y return of 261.0% underscores its role in AI data centers, positioning MU as a top growth pick in tech analysis.
Key Catalysts
- Phenomenal 261.0% 1Y return from AI-driven memory demand
- 45.4% revenue growth and 40.9% FCF margin
- High ROIC of 25.4% reflecting efficient scaling
- Low debt at 20.2% for balance sheet strength
Risk Factors
- Commodity-like memory pricing cycles
- Dependence on tech sector capex
- Supply chain vulnerabilities
Most investors waste time on the wrong metrics. We've spent 10,000+ hours perfecting our value investing engine to find what actually matters.
Want to see what we'll uncover next - before everyone else does?
Find Hidden Gems First!
Stock #5: Thermo Fisher Scientific Inc. (TMO)
| Metric | Value |
|---|---|
| Market Cap | $223.2B |
| Quality Rating | 6.0 |
| Intrinsic Value | $642.5 |
| 1Y Return | 13.4% |
| Revenue | $43.7B |
| Free Cash Flow | $6,111.0M |
| Revenue Growth | 3.2% |
| FCF margin | 14.0% |
| Gross margin | 40.8% |
| ROIC | 8.3% |
| Total Debt to Equity | 69.9% |
Investment Thesis
Thermo Fisher Scientific Inc. (TMO) has a Quality rating of 6.0 and intrinsic value of $642.5, market cap $223.2B. It features revenue of $43.7B, free cash flow of $6,111.0M, revenue growth of 3.2%, FCF margin of 14.0%, gross margin of 40.8%, ROIC of 8.3%, and Total Debt to Equity of 69.9%. Modest 1Y return of 13.4% highlights stability in life sciences tools for healthcare investors.
Key Catalysts
- Steady revenue base of $43.7B in essential lab equipment
- Intrinsic value upside to $642.5
- Diversified healthcare exposure
- Improving FCF margins over time
Risk Factors
- Moderate debt at 69.9% Total Debt to Equity
- Slow 3.2% revenue growth
- Biotech funding cycles
Stock #6: Intel Corporation (INTC)
| Metric | Value |
|---|---|
| Market Cap | $177.8B |
| Quality Rating | 5.1 |
| Intrinsic Value | $76.6 |
| 1Y Return | 94.8% |
| Revenue | $53.4B |
| Free Cash Flow | ($7,251.0M) |
| Revenue Growth | (1.5%) |
| FCF margin | (13.6%) |
| Gross margin | 35.8% |
| ROIC | (1.3%) |
| Total Debt to Equity | 39.9% |
Investment Thesis
Intel Corporation (INTC) shows a Quality rating of 5.1 and intrinsic value of $76.6, with $177.8B market cap. Metrics: revenue $53.4B, free cash flow $7,251.0M, revenue growth 1.5%, FCF margin 13.6%, gross margin 35.8%, ROIC 1.3%, Total Debt to Equity 39.9%, and 1Y return 94.8%. Despite challenges, turnaround potential in chips makes it a value play.
Key Catalysts
- 94.8% 1Y return from foundry investments
- Large revenue base for recovery
- Strategic shift to AI and manufacturing
Risk Factors
- Negative FCF and ROIC signaling operational issues
- Declining revenue growth
- Intense competition from TSM and others
Stock #7: Uber Technologies, Inc. (UBER)
| Metric | Value |
|---|---|
| Market Cap | $173.2B |
| Quality Rating | 7.2 |
| Intrinsic Value | $161.4 |
| 1Y Return | 31.2% |
| Revenue | $49.6B |
| Free Cash Flow | $8,661.0M |
| Revenue Growth | 18.2% |
| FCF margin | 17.5% |
| Gross margin | 39.7% |
| ROIC | 91.6% |
| Total Debt to Equity | 41.8% |
Investment Thesis
Uber Technologies, Inc. (UBER) earns Quality rating 7.2 and intrinsic value $161.4, market cap $173.2B. Highlights: revenue $49.6B, FCF $8,661.0M, revenue growth 18.2%, FCF margin 17.5%, gross margin 39.7%, ROIC 91.6%, Total Debt to Equity 41.8%, 1Y return 31.2%. Mobility platform profitability drives appeal.
Key Catalysts
- Outstanding ROIC of 91.6%
- 18.2% revenue growth in ride-sharing
- Positive FCF inflection
- Global expansion opportunities
Risk Factors
- Regulatory hurdles in gig economy
- 41.8% debt levels
- Competition in delivery services
Stock #8: The Boeing Company (BA)
| Metric | Value |
|---|---|
| Market Cap | $168.1B |
| Quality Rating | 4.7 |
| Intrinsic Value | $304.1 |
| 1Y Return | 32.5% |
| Revenue | $80.8B |
| Free Cash Flow | ($4,364.0M) |
| Revenue Growth | 10.2% |
| FCF margin | (5.4%) |
| Gross margin | 1.1% |
| ROIC | (7.9%) |
| Total Debt to Equity | (646.5%) |
Investment Thesis
The Boeing Company (BA) has Quality rating 4.7 and intrinsic value $304.1, $168.1B market cap. Data: revenue $80.8B, FCF $4,364.0M, revenue growth 10.2%, FCF margin 5.4%, gross margin 1.1%, ROIC 7.9%, Total Debt to Equity 646.5%, 1Y return 32.5%. Aerospace recovery analysis focuses on order backlog.
Key Catalysts
- 10.2% revenue growth from commercial aviation
- 32.5% 1Y return amid rebound
- Massive backlog potential
Risk Factors
- Severe negative gross margin and ROIC
- High negative debt ratio
- Production and safety issues
Stock #9: BHP Group Limited (BHP)
| Metric | Value |
|---|---|
| Market Cap | $156.1B |
| Quality Rating | 6.6 |
| Intrinsic Value | $65.2 |
| 1Y Return | 28.0% |
| Revenue | $107.3B |
| Free Cash Flow | $20.7B |
| Revenue Growth | (10.1%) |
| FCF margin | 19.3% |
| Gross margin | 48.7% |
| ROIC | 28.5% |
| Total Debt to Equity | 46.9% |
Investment Thesis
BHP Group Limited (BHP) features Quality rating 6.6 and intrinsic value $65.2, $156.1B market cap. Metrics: revenue $107.3B, FCF $20.7B, revenue growth 10.1%, FCF margin 19.3%, gross margin 48.7%, ROIC 28.5%, Total Debt to Equity 46.9%, 1Y return 28.0%. Commodities strength in mining.
Key Catalysts
- High ROIC 28.5% and FCF $20.7B
- 48.7% gross margin resilience
- Diversified metals portfolio
Risk Factors
- Declining revenue growth
- Commodity price volatility
- 46.9% leverage exposure
Stock #10: Sony Group Corporation (SONY)
| Metric | Value |
|---|---|
| Market Cap | $154.3B |
| Quality Rating | 6.2 |
| Intrinsic Value | $24.2 |
| 1Y Return | 22.7% |
| Revenue | ¥12.8T |
| Free Cash Flow | ¥1,715.2B |
| Revenue Growth | (2.9%) |
| FCF margin | 13.4% |
| Gross margin | 29.1% |
| ROIC | 21.3% |
| Total Debt to Equity | 20.1% |
Investment Thesis
Sony Group Corporation (SONY) has Quality rating 6.2 and intrinsic value $24.2, $154.3B market cap. Includes revenue ¥12.8T, FCF ¥1,715.2B, revenue growth 2.9%, FCF margin 13.4%, gross margin 29.1%, ROIC 21.3%, Total Debt to Equity 20.1%, 1Y return 22.7%. Entertainment and electronics diversification.
Key Catalysts
- Strong ROIC 21.3% across segments
- Positive FCF generation
- Gaming and content growth potential
Risk Factors
- Mild revenue contraction
- Currency fluctuations for yen-based ops
- Consumer electronics competition
Portfolio Diversification Insights
This stock watchlist balances tech heavyweights like TSM and MU (high growth, semiconductors) with healthcare (ABBV, TMO), consumer tech (BABA, UBER, SONY), industrials (BA, INTC), and commodities (BHP). Sector allocation: ~50% technology, 20% healthcare, 15% consumer/discretionary, 10% industrials, 5% materials. High-quality picks (e.g., TSM's 8.2 rating) complement turnaround stories (e.g., INTC), reducing correlation risks. Cross-references show tech leaders boosting portfolio ROIC, while commodities add inflation hedges.
Market Timing & Entry Strategies
Consider positions during sector dips, such as semiconductor cycles for TSM/MU or commodity rebounds for BHP. Monitor intrinsic value gaps—enter when prices approach 20-30% below estimates. Use dollar-cost averaging for volatile names like BABA, scaling in on earnings beats. Track 1Y returns for momentum confirmation, pairing with Value Sense screeners for backtested entry signals.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2025)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!
More Articles You Might Like
- Nelson Peltz - Trian Fund Management Portfolio Q3'2025: Top Holdings & Recent Changes
- Principles for Dealing with the Changing World Order by Ray Dalio
- The Ascent of Money by Niall Ferguson
- Principles for Navigating Big Debt Crises by Ray Dalio
- Influence: The Psychology of Persuasion by Robert B. Cialdini Ph.D.
FAQ Section
How were these stocks selected?
These 10 best stock picks were chosen via Value Sense criteria emphasizing high intrinsic value upside, quality ratings above 4.5, positive 1Y returns, and strong ROIC/FCF metrics for diversified undervalued stocks.
What's the best stock from this list?
Micron (MU) leads with 261.0% 1Y return, 8.2 quality rating, and 45.4% revenue growth, though TSM excels in stability with top ROIC.
Should I buy all these stocks or diversify?
Diversification across sectors like tech and healthcare mitigates risks; allocate based on portfolio needs rather than holding all, using tools like Value Sense watchlists.
What are the biggest risks with these picks?
Key concerns include high debt (e.g., ABBV, BA), negative FCF (BABA, INTC), and cyclical exposures (semiconductors, commodities).
When is the best time to invest in these stocks?
Optimal during market pullbacks when prices widen intrinsic value gaps; monitor quarterly earnings and sector trends for entry points.